Invention Grant
- Patent Title: Reverse genetics system of Zika virus
-
Application No.: US16098401Application Date: 2017-05-03
-
Publication No.: US10533997B2Publication Date: 2020-01-14
- Inventor: Pei-Yong Shi , Chao Shan , Xuping Xie
- Applicant: Pei-Yong Shi , Chao Shan , Xuping Xie
- Applicant Address: US TX Austin
- Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US TX Austin
- Agency: Norton Rose Fulbright US LLP
- International Application: PCT/US2017/030810 WO 20170503
- International Announcement: WO2017/192701 WO 20171109
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/12 ; C12N7/00 ; A61K45/06 ; C07H19/20 ; G01N33/569 ; C12Q1/70 ; C12Q1/6897
Abstract:
Embodiments of the invention are directed to stable full-length cDNA clones of a clinical, Asian lineage ZIKV strain. Certain embodiments of the invention are directed to high-throughput assays for ZIKV and dengue virus (DENV) diagnosis.
Public/Granted literature
- US20190120841A1 Reverse Genetics System of Zika Virus Public/Granted day:2019-04-25
Information query
